Press Release: Flexion Therapeutics : Flexion Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

BURLINGTON, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN) announced today that Michael Clayman, M.D., President and Chief Executive Officer, will...